Neogen Corporation (NEOG) Cash Flow Statement

The persistent gap between net income and operating cash flow is largely attributable to substantial non-cash charges, including D&A averaging around $30M per quarter and merger-related impairments. This suggests that the reported losses overstate the cash burn, but the negative OCF/NI ratios (e.g., -2.67 in 2026Q4) indicate that earnings quality is distorted by one-time items. Investors should monitor whether the positive cash generation can be sustained as integration costs subside.

The FCF margin has been highly volatile, ranging from -27.3% to 19.3%, but the most recent quarters show a narrowing of losses, with 2026Q3 and 2026Q2 posting positive FCF. This suggests that the integration-related cash drag may be easing, though the negative FCF in 2026Q4 indicates that working capital demands remain unpredictable. The trajectory appears to be stabilizing, but a sustained positive FCF margin is not yet evident.

The elevated capital intensity relative to revenue (typically 5-15%) suggests that Neogen is investing heavily in capacity and infrastructure to support the expanded 3M Food Safety business. While some of this spending may be growth-oriented, the high depreciation charges (around $30M quarterly) imply a substantial maintenance component. Investors should assess whether the increased capital base will generate sufficient returns to justify the spending, especially given the current sub-2% operating margin.

The erratic working capital movements, particularly the large negative swing in 2024Q3 and the positive contributions in recent quarters, suggest that Neogen is managing its receivables and inventory aggressively, possibly to offset integration-related disruptions. The positive working capital inflows in 2026Q4 and 2026Q1 may indicate improved collection efficiency, but the sustainability is uncertain given the revenue decline. Investors should monitor whether working capital becomes a consistent source or use of cash.

The complete absence of dividends and buybacks indicates that management is prioritizing balance sheet flexibility and integration-related spending over shareholder returns. The $121.7M acquisition outflow in 2026Q1 likely relates to the 3M Food Safety deal, suggesting that capital deployment is focused on integration rather than returning cash. This is consistent with a company in transition, but investors should expect a shift toward capital returns once free cash flow stabilizes.

The stark contrast between cumulative net losses and positive operating cash flow underscores the impact of non-cash impairments and amortization, particularly the $612.2M loss in 2025Q4. This suggests that the underlying cash-generating ability of the business is stronger than GAAP earnings imply, but it also raises questions about the sustainability of the asset base. Investors should focus on cash flow metrics to gauge the true economic performance, while remaining cautious about the potential for further write-downs.